Renal neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 expression in children with acute kidney injury and Henoch-Schönlein purpura nephritis

Experimental and Therapeutic Medicine

Volumn 7, Issue 5, 2014, Pages 1130-1134

  Du, Yue ^a   Hou, Ling ^a   Guo, Jinjie ^a   Sun, Tingting ^a   Wang, Xiuli ^a   Wu, Yubin ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Acute kidney injury; Children; Henoch Sch nlein purpura nephritis; Injury molecule 1; Renal neutrophil gelatinase associated lipocalin

Indexed keywords

BETA 2 MACROGLOBULIN; CREATININE; CYSTATIN C; KIDNEY INJURY MOLECULE 1; MACROGLOBULIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ARTICLE; CHILD; CLINICAL ARTICLE; CREATININE CLEARANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; GLOMERULUS FILTRATION RATE; HENOCH SCHONLEIN PURPURA NEPHRITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEPHRITIS; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RENAL TUBULAR EPITHELIAL CELL; SCHOOL CHILD; URINALYSIS;

EID: 84896889360     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1595     Document Type: Article

References (32)

1. Xue JL, Daniels F, Star RA, et al: Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 17: 1135-1142, 2006.
2. Liaño F and Pascual J: Epidemiology of acute renal failure: A prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int 50: 811-818, 1996.
3. Pisoni R, Wille KM and Tolwani AJ: The epidemiology of severe acute kidney injury: from BEST to PICARD, in acute kidney injury: new concepts. Nephron Clin Pract 109: c188-c191, 2008.
4. Vachvanichsanong P, Dissaneewate P, Lim A and McNeil E: Childhood acute renal failure: 22-year experience in a university hospital in southern Thailand. Pediatrics 118: e786-e791, 2006.
5. Hui-Stickle S, Brewer ED, Goldstein SL: Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 45: 96-101, 2005.
6. Ronkainen J, Ala-Houhala M, Huttunen NP, JahnukainenT, Koskimies O, Ormälä T and Nuutinen M: Outcome of Henoch-Schonlein nephritis with nephrotic-range proteinuria. Clin Nephrol60: 80-84, 2003.
7. Shenoy M, Bradbury MG, Lewis MA and Webb NJ: Outcome of Henoch-Schönlein purpura nephritis treated with long-term immunosuppression. Pediatr Nephrol 22: 1717-1722, 2007.
8. Coppo R, Andrulli S, Amore A, et al: Prediction of outcome in Henoch-Schönlein Nephritis in children and adults. Am J Kidney Dis47: 993-1003, 2006.
9. Supavekin S, Zhang W, Kucherlapati R, et al: Differential gene expression following early renal ischemia/reperfusion. Kidney Int63: 1714-1724, 2003.
10. Mishra J, Ma Q, Prada A, et al: Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14: 2534-2543, 2003.
11. Mishra J, Mori K, Ma Q, et al: Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrolol 24: 307-315, 2004.
12. Mishra J, Mori K, Ma Q, et al: Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 15: 3073-3082, 2004.
13. Devarajan P, Mishra J, Supavekin S, et al: Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol Genet Metab80: 365-376, 2003.
14. Devarajan P: Cellular and molecular derangements in acute tubular necrosis. Curr Opin Pediatr 17: 193-199, 2005.
15. Nguyen MT, Ross GF, Dent CL, et al: Early prediction of acute renal injury using urinary proteomics. Am J Nephrol25: 318-326, 2005.
16. Mishra J, Ma Q, Kelly C, et al: Kidney NGAL is a novel marker of acute injury following transplantation. Pediatr Nephrol21: 856-863,2006.
17. Mishra J, Dent C, Tarabishi R, et al: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365: 1231-1238, 2005.
18. Davide B, Antonio L, Giuseppe C, et al: Neutrophil gelatinase-associated lipocalin (NGAL) and progession of chronic kidney disease. Clin J Am Nephrol 4: 337-344, 2009.
19. Dent CL, Ma Q, Dastrala S, et al: Plasma NGAL predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care11: R127, 2007.
20. Parikh CR, Jani A, Mishra J, et al: Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 6: 1639-1645, 2006.
21. Trachtman H, Christen E, Cnaan A, et al: Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury. Pediatr Nophrol21: 989-994, 2006.
22. Hirsch R, Dent C, Pfriem H, et al: NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol 22: 2089-2095, 2007.
23. Vaidya VS, Ramirez V, Ichimura T, et al: Urinary kidney injury molecule-1: A sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol290: F517-F529, 2006.
24. Zhang Z, Humphreys BD and Bonventre JV: Shedding of the urinary biomarker kidney injury molecule-1 (KIM-1) is upregulated by MAP kinases and juxtamembrane region. J Am Soc Nephrol 18: 2702-2714, 2007.
25. van Timmeren MM, van den Heuvel MC, Bailly V, et al: Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol 212: 209-217, 2007.
26. van Timmeren MM, Bakker SJ, Vaidya VS, et al: Tubular kidney injury molecule-1 in protein overload nephropathy. Am J Physiol Renal Physiol 291: F456-F464, 2006.
27. Akcan-Arikan A, Zappitelli M, Loftis LL, et al: Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 71: 1028-1035, 2007.
28. Schwartz GJ, Brion LP and Spitzer A: The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents. Pediatr Clin North Am34: 571-590, 1987.
29. Clinical practice guideline for acute kidney injury; KDIGO (Kidney Disease: Improving Global Outcome), 2: 124-138, 2012.
30. Davin JC and Weening JJ: Henoch-Schönlein purpura nephritis: an update. Eur J Pediatr 160: 689-695, 2001.
31. Lau KK, Suzuki H, Novak J and Wyatt RJ: Pathogenesis of Henoch-Schönlein purpura nephritis. Pediatr Nephrol 25: 19-26, 2010.
32. Pitashny M, Schwartz N, Qing X, et al: Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis. Arthritis Rheum 56: 1894-1903, 2007.